Stocks · Korea
023910
KOSDAQ
DaehanPharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER5.51x
PBR0.51x
EPS4,701 KRW
BPS51,057 KRW
ROE8.96%
Dividend yield3.86%
DPS1,000 KRW
Payout ratio21.27%
Returns and 52-week range
1W-0.77%
1M-4.95%
3M+0.19%
6M-11.00%
1Y-13.23%
YTD-9.91%
52W high31,700원
52W low24,000원
From 52W high-18.30%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,843억 | 330억 | 250억 | 17.9% |
| 2023 | 1,959억 | 358억 | 284억 | 18.3% |
| 2024 | 2,042억 | 381억 | 338억 | 18.6% |
| 2025 | 2,086억 | 312억 | 276억 | 14.9% |
| Quarterly | ||||
| 2024 4Q | 514억 | 87억 | 90억 | 17.0% |
| 2025 1Q | 499억 | 92억 | 76억 | 18.5% |
| 2025 2Q | 515억 | 77억 | 62억 | 15.1% |
| 2025 3Q | 562억 | 106억 | 87억 | 18.9% |
| 2025 4Q | 511억 | 36억 | 51억 | 7.0% |
| 2026 1Q | 527억 | 79억 | 70억 | 14.9% |
Company
Address: 서울특별시 영등포구 선유로45길 3
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.